The global Blood Flow Measurement Devices Market is estimated to be valued at US$ 695.78 Mn in 2023 and is expected to exhibit a CAGR of 8.8% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.
Market Overview:
Blood flow measurement devices are used to measure volumetric blood flow in the arteries and veins of the body. Some common types of blood flow measurement devices include Ultrasonic Doppler, Laser Doppler, Electromagnetic and Speckle Microscopy. Ultrasonic Doppler devices work on the principle of Doppler effect to detect the velocity of red blood cells and determine volumetric flow. Laser Doppler devices utilize laser light which gets scattered by moving red blood cells in tissue to calculate blood flow. Electromagnetic sensors utilize the conductivity of blood to determine flow volume. Speckle microscopy analyzes images of blood flow microcirculation obtained through specialized microscopes. These devices help in non-invasive and accurate measurement of peripheral arterial disease, cardio diseases, hemodialysis adequacy and microcirculatory conditions.
Market key trends:
One of the key trends in the blood flow measurement devices market is the growing demand for non-invasive and portable devices. This is owing to the increasing preference of patients and physicians for pain-free diagnostic procedures. Manufacturers are focusing on developing compact and lightweight devices that can easily be used at the point-of-care or in ambulatory settings. Another trend is the introduction of advanced technologies like thermal sensors, laser interferometry and smartphone integration which is helping improve accuracy and efficiency of blood flow measurements. Integration of artificial intelligence capabilities is also gaining traction as it allows automated analysis of complex blood flow waveform data obtained from measurements.
Porter’s Analysis
Threat of new entrants: The threat of new entrants is moderate as the blood flow measurement devices market requires high R&D investment and regulatory approvals. Bargaining power of buyers: The bargaining power of buyers is moderate as they have a choice from multiple providers and their purchases do not make a significant impact on providers’ businesses. Bargaining power of suppliers: The bargaining power of suppliers is low due to the availability of a large number of component suppliers for blood flow measurement devices. Threat of new substitutes: The threat of new substitutes is low as there are limited substitutes available for blood flow measurement devices. Competitive rivalry: High.
Key Takeaways
The Global Blood Flow Measurement Devices Market Demand is expected to witness high growth, exhibiting CAGR of 8.8% over the forecast period, due to increasing geriatric population and prevalence of cardiovascular diseases.
Regional analysis
North America is expected to dominate the global blood flow measurement devices market during the forecast period. This is attributed to the increasing prevalence of cardiovascular diseases, developed healthcare infrastructure, and rising healthcare spending in the region. The Asia Pacific is anticipated to exhibit the fastest growth rate over the forecast period due to large population base and improving healthcare infrastructure.
Key players
Key players operating in the blood flow measurement devices market include Arjo, Atys Medical, Compumedics Ltd., Cook Medical Inc., Deltex Medical Ltd., GF Health Products, Inc., Medistim ASA, Moor Instruments Ltd., Perimed AB, Transonic Systems, Inc., Medtronics, Biomedix Inc, AKW Medicals Inc., D E Hokanson Inc., Elcat GmBH, Flowtronics Inc.
*Note:
1. Source: Coherent Market Insights, Public sources, Desk research
2. We have leveraged AI tools to mine information and compile it
